Ukuguqulwa kwamaphuzu ofuzweni lwe-KRAS kuyathinteka ohlotsheni lwamathumba abantu, ngamazinga okuguquka acishe abe ngu-17%–25% kuzo zonke izinhlobo zesimila, 15%–30% kumdlavuza wamaphaphu, kanye nama-20%–50% kumdlavuza wekoloni. Lezi zinguquko ziqhuba ukumelana nokwelashwa nokuqhubekela phambili kwesimila ngokusebenzisa indlela ebalulekile: iphrotheni ye-P21 efakwe ikhodi yi-KRAS isebenza ezansi nomfula wendlela yokusayina ye-EGFR. Uma i-KRAS isiguquliwe, yenza kusebenze ukusayinda komfula ngokuqhubekayo, inikeze izindlela zokwelapha eziqondiswe phezulu ne-EGFR zingasebenzi futhi okuholela ekwandeni kwamaseli ayingozi okuqhubekayo. Ngenxa yalokho, ukuguqulwa kwe-KRAS kuhlotshaniswa nokumelana ne-EGFR tyrosine kinase inhibitors kumdlavuza wamaphaphu kanye nokwelashwa kwe-anti-EGFR antibody kumdlavuza we-colorectal.

Ngo-2008, i-National Comprehensive Cancer Network (NCCN) yasungula imihlahlandlela yomtholampilo encoma ukuhlolwa kokuguqulwa kwe-KRAS kuzo zonke iziguli ezinomdlavuza we-metastatic colorectal (mCRC) ngaphambi kokwelashwa. Imihlahlandlela igqamisa ukuthi iningi lokuguqulwa kokuguqulwa kwe-KRAS kusebenze kwenzeka ku-codon 12 kanye ne-13 ye-exon 2. Ngakho, ukutholwa kokuguqulwa kwe-KRAS okusheshayo nokunembile kubalulekile ukuze kuqondiswe ukwelashwa okufanele komtholampilo.

Kungani Ukuhlolwa Kwe-KRAS KubalulekileMetastaticCi-olorectalCumdlavuza(mCRC)

Umdlavuza we-Colorectal (CRC) akusona isifo esisodwa kodwa iqoqo lama-subtypes ahlukile we-molecularly. Izinguquko ze-KRAS—ezikhona cishe ku-40–45% weziguli ze-CRC—zisebenza njengokushintshwa “okuvuliwe” okuqhubekayo, okugqugquzela ukukhula komdlavuza ngaphandle kwezimpawu zangaphandle. Ezigulini ezine-mCRC, isimo se-KRAS sinquma ukusebenza kahle kwamasosha omzimba alwa ne-EGFR njenge-Cetuximab ne-Panitumumab:

I-KRAS yohlobo lwasendle:Iziguli kungenzeka zizuze ekwelashweni kwe-anti-EGFR.

I-Mutant KRAS:Iziguli azizuzi lutho kulawa ma-ejenti, ezibeka engcupheni imiphumela engemihle engadingekile, izindleko ezikhuphukile, nokubambezeleka kokwelashwa okuphumelelayo.

Ngakho-ke ukuhlolwa kwe-KRAS okunembe nokuzwelayo kuyisisekelo sokuhlela ukwelashwa komuntu siqu.

Inselele Yokuthola: Ukuhlukanisa Isignali Yokuguqulwa

Izindlela zosiko zivame ukungabi nokuzwela ekuguqulweni kwenani eliphansi, ikakhulukazi kumasampuli anokuqukethwe kwesimila esiphansi noma ngemva kokususwa kwezibalo. Ubunzima busekuhlukaniseni isignali ye-DNA eguquguqukayo ebuthakathaka ngokumelene nesizinda sohlobo lwasendle oluphakeme—kufana nokuthola inaliti esitakini sotshani. Imiphumela enganembile ingaholela ekwelapheni okungalungile kanye nemiphumela esengozini.

Isixazululo Sethu: I-Precision-Engineered for Confident Mutation Detection

Ikhithi yethu yokutholwa kokuguqulwa kwe-KRAS ihlanganisa ubuchwepheshe obuthuthukisiwe ukuze inqobe le mikhawulo, ilethe ukunemba okukhethekile nokwethembeka kwesiqondiso sokwelashwa kwe-mCRC.

Indlela Ubuchwepheshe Bethu Iqinisekisa Ngayo Ukusebenza Okuphakeme

• Ubuchwepheshe obuthuthukisiwe be-ARMS (Isistimu Yokuguqula I-Amplification Refractory): Yakha phezu kobuchwepheshe be-ARMS, obuhlanganisa ubuchwepheshe bokuqinisekisa ubunikazi ukuze kwandiswe ukucaciswa kokutholwa.
• Ukucebisa nge-Enzymatic: Kusebenzisa ama-endonuclease anomkhawulo ukuze kugaywe iningi lesizinda sohlobo lwasendle lomuntu, konga izinhlobo eziguqukayo, ngaleyo ndlela kuthuthukise ukutholwa nokunciphisa ukukhuliswa okungaqondile ngenxa yesizinda sofuzo esiphezulu.
• Ukuvinjwa Kwezinga Lokushisa: Kwethula izinyathelo ezithile zokushisa enqubweni ye-PCR, okubangela ukungafani phakathi kweziqalo eziguqukayo nezifanekiso zohlobo lwasendle, ngaleyo ndlela kunciphisa ingemuva lohlobo lwasendle futhi kuthuthukiswe ukutholwa.
• Ukuzwela Okuphezulu: Ithola ngokunembile okuphansi njengo-1% we-DNA eguqukayo.
• Ukunemba Okuhle Kakhulu: Isebenzisa izindinganiso zangaphakathi kanye ne-enzyme ye-UNG ukuvimbela imiphumela engalungile nengalungile.
• Kulula futhi Kuyashesha: Iqeda ukuhlola cishe emizuzwini eyi-120, isebenzisa amashubhu okusabela amabili ukusiza ukutholwa kwezinguquko ezihlukene eziyisishiyagalombili, inikeze inhloso kanye nemiphumela ethembekile.
• Ukuhambelana Kwensimbi: Ijwayela amathuluzi ahlukahlukene e-PCR.

Umuthi onembile kumdlavuza we-colorectal uqala ngokuxilonga amangqamuzana. Ngokwamukela Ikhithi Yokutholwa Kwezinguquko Ze-KRAS, ilabhorethri yakho ingaletha imiphumela eqinisekile, esebenzayo elolonge ngokuqondile indlela yokwelashwa yesiguli.

Nika ilebhu yakho amandla ngobuchwepheshe obuthembekile, obusezingeni eliphezulu—futhi unike amandla ukunakekelwa komuntu siqu ngempela.

Xhumana nathi: marketing@mmtest.Com

Funda kabanzi mayelana nokuhlanganisa lesi sixazululo esithuthukisiwe ekuhambeni kwakho kokuxilonga.

#Colorectal #Cancer #DNA #Mutation #Precision #Targeted #Ukwelashwa #Cancer

Ukuvula Umuthi Onembile kuCancer Colorectal